Tempest Therapeutics, Inc. (TPST)
0.89
-0.02
(-2.08%)
USD |
NASDAQ |
Sep 10, 10:12
Tempest Therapeutics Debt to Equity Ratio : -6.936 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.936 |
| March 31, 2026 | 9.555 |
| December 31, 2025 | 1.221 |
| September 30, 2025 | 1.324 |
| June 30, 2025 | 0.8855 |
| March 31, 2025 | 1.177 |
| December 31, 2024 | 0.8034 |
| September 30, 2024 | 1.548 |
| June 30, 2024 | 1.196 |
| March 31, 2024 | 0.9873 |
| December 31, 2023 | 0.7719 |
| September 30, 2023 | -17.65 |
| June 30, 2023 | 4.286 |
| March 31, 2023 | 1.975 |
| December 31, 2022 | 1.221 |
| September 30, 2022 | 0.6241 |
| June 30, 2022 | 0.488 |
| March 31, 2022 | 0.6218 |
| December 31, 2021 | 0.5132 |
| September 30, 2021 | 0.4322 |
| June 30, 2021 | 0.3972 |
| March 31, 2021 | 0.0985 |
| December 31, 2020 | 0.1406 |
| September 30, 2020 | 0.0772 |
| June 30, 2020 | 0.0786 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0722 |
| December 31, 2019 | 0.0772 |
| September 30, 2019 | 0.115 |
| June 30, 2019 | 0.0724 |
| March 31, 2019 | 0.038 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.633M |
| Total Liabilities (Quarterly) | 10.72M |
| Shareholders Equity (Quarterly) | -1.09M |
| Current Ratio | 0.3813 |
| Net Debt Paydown Yield | 6.25% |